Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Europe vs the US: New drug product approvals

As US approvals rates in the US drop,  the EU is not currently showing a similar trend

- PMLiVE

UK signals desire for close post-Brexit relationship with EU

Health and business ministers outline areas where collaboration may continue

Roche acquires digital diabetes management platform

Will integrate mySugr within its new patient-centred health services arm

- PMLiVE

Fishawack appoints Jenifer Kirkland as CFO

She succeeds Dominic Miller who becomes COO at the med comms agency

- PMLiVE

EMA and FDA calls for innovative approaches for Gaucher disease medicines

The regulatory agencies also urge a similar method for all paediatric diseases

- PMLiVE

Your doctor has no time to see you now

Changing the way HCPs connect with each other to positively impact the fraying patient-doctor relationship

- PMLiVE

FDA moves to tackle orphan designation backlog

Some 200 requests are awaiting review by the US regulator

- PMLiVE

GSK signs up to apply AI to drug discovery

Will work with Exscientia on 10 small molecule targets

GSK signs up to apply AI to drug discovery

Will work with Exscientia on 10 small molecule targets

Internships: Growing the pool of recruitable talent, or cheap labour?

How 'try before you buy' can be an enormous help in medical communications

What makes the difference in the biosimilar battle?

The biosimilar market is set to get competitive but only players with a clear differentiation will succeed

National Institute for Health and Care Excellence NICE logo

NICE backs Lilly’s rheumatoid arthritis drug Olumiant

The drug will be used alongside methotrexate to treat adults with severe, active RA

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links